Psychoactive Drug Screening

Ferkany, John W.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Mental Health (NIMH)
• Type: Research and Development Contracts (N01)
• Project #: N01MH020003-010
• Application #: 2320822
• Project Start: 1992-07-01
• Project End: 1996-12-31
• Budget Start: 1996-03-25
• Budget End: 1996-12-31
• Fiscal Year: 1996

Institution

• Name: Nova Pharmaceutical Corporation
• City: Baltimore
• State: MD
• Country: United States
• Zip Code: 21224

Publications

Damaj, M I; Glassco, W; Marks, M J et al. (1997) Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog. J Pharmacol Exp Ther 282:1425-34